Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 6616 AL 6630

Rehabilitation of Women with Neurodegenerative Diseases

Markos S, Galibov M.

Phys Med Rehabil Clin N Am. 2025 May;36(2):389-398. doi: 10.1016/j.pmr.2024.11.006. Epub 2024 Dec 10.

Emerging roles of microglia and neuroinflammation in Huntington's disease: From pathophysiology to clinical trials

Abedrabbo M, Kazemian P, Connolly C, Leavitt BR.

J Huntingtons Dis. 2025 Aug;14(3):241-257. doi: 10.1177/18796397251330144. Epub 2025 Mar 28.

Advances in Huntington's Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review

Aqel S, Ahmad J, Saleh I, Fathima A, Al Thani AA, Mohamed WMY, Shaito AA.

Biology (Basel). 2025 Jan 26;14(2):129. doi: 10.3390/biology14020129.

Nutrition and Huntington's Disease- A Review of Current Practice and Theory

Gaba A.

Curr Nutr Rep. 2025 Jan 16;14(1):18. doi: 10.1007/s13668-025-00610-x.

Progress on 3-Nitropropionic Acid Derivatives

Feng ML, Li ZH, Shi BB.

Biomolecules. 2025 Jul 24;15(8):1066. doi: 10.3390/biom15081066.

Oligonucleotide-based therapeutics for neurodegenerative disorders: Focus on antisense oligonucleotides

Mansour HM, El-Khatib AS.

Eur J Pharmacol. 2025 Jul 5;998:177529. doi: 10.1016/j.ejphar.2025.177529. Epub 2025 Mar 19.

Neuroimaging Techniques in Huntington's Disease: A Critical Review

Farag M, Knights H, Scahill RI, McColgan P, Estevez-Fraga C.

Mov Disord Clin Pract. 2025 May;12(5):561-576. doi: 10.1002/mdc3.70010. Epub 2025 Feb 20.

Huntington's disease LIG1 modifier variant increases ligase fidelity and suppresses somatic CAG repeat expansion

Lee E, Kim W, Beier DH, Lee Y, Kovalenko M, Saif F, Oliver E, Murtha R, Andrew MA, Gillis T, Demelo B, Srinageshwar B, Ruliera J, Lucente D, Kwak S, Lee R, Pinto RM, MacDonald ME, Gusella JF, O'Brien PJ, Wheeler VC, Seong IS.

bioRxiv [Preprint]. 2025 Jul 18:2025.07.15.664798. doi: 10.1101/2025.07.15.664798.

Application of antisense oligonucleotide drugs in amyotrophic lateral sclerosis and Huntington's disease

Ou K, Jia Q, Li D, Li S, Li XJ, Yin P.

Transl Neurodegener. 2025 Jan 21;14(1):4. doi: 10.1186/s40035-025-00466-9.

Mitochondrial-Derived Peptides: Implication in the Therapy of Neurodegenerative Diseases

Thakur R, Chauhan A, Moudgil H, Singh S, Devi R.

Mol Neurobiol. 2025 Dec;62(12):15871-15884. doi: 10.1007/s12035-025-05198-5. Epub 2025 Jul 26.

Treatment of Huntington's disease with a pan-HTT-targeting CRISPR nuclease

Tan K, Siller DDB, Xiong AY, Wang AXA, McCallister TX, Mummadi S, St John LA, Lee TK, Carrillo A, Renshaw DG, Zhou RH, Lim CKW, He J, Fields CJ, Hayden MR, Gaj T.

bioRxiv [Preprint]. 2025 Dec 22:2025.12.20.695720. doi: 10.64898/2025.12.20.695720.

Blocking somatic repeat expansion and lowering huntingtin via RNA interference synergize to prevent Huntington's disease pathogenesis in mice

Belgrad J, Summers A, Landles C, Greene JR, Hildebrand S, Knox E, Sapp E, Yamada N, Furgal R, Miller R, Osborne GF, Chase K, Luu E, Freedman J, Bramato B, McHugh N, Benoit V, O'Reilly D, Greer P, Bates GP, Vogt TF, Lee R, Howland D, DiFiglia M, Aronin N, Khvorova A.

bioRxiv [Preprint]. 2025 Jun 25:2025.06.24.661398. doi: 10.1101/2025.06.24.661398.

Comparison of tetrabenazine, tiapride and olanzapine in Huntington's disease: a one-year French randomized multicenter study (Neuro-HD)

Youssov K, Audureau E, Pariente J, Azulay JP, Benatru I, Durr A, Krystkowiak P, Marelli C, Tranchant C, Simonin C, Verny C; Huntington French speaking network; Bachoud-Lévi AC.

Parkinsonism Relat Disord. 2025 Nov;140:108017. doi: 10.1016/j.parkreldis.2025.108017. Epub 2025 Sep 3.

NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies

Zhang K, Wen M, Nan X, Zhao S, Li H, Ai Y, Zhu H.

Front Aging Neurosci. 2025 Jul 24;17:1604378. doi: 10.3389/fnagi.2025.1604378. eCollection 2025.

CRISPR-based gene therapy for huntington's disease: current advances and future prospects

Zaheer A, AboQuella NM, Wadan AS, Saad HA, Kumar D, Panjwani S, Rath S, Ahmed SI.

Neurogenetics. 2025 Oct 31;26(1):76. doi: 10.1007/s10048-025-00858-z.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias